Home

Insights

Aurobindo Pharma Ltd P/E Ratio

Aurobindo Pharma Ltd P/E Ratio

download
stocks purchased

₹ 1.1 Cr

Volume transacted

stocks purchased

9.1 K

stocks traded

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

PE

24.2

Last updated : 20 May 06:47 AM

Key Highlights

    The P/E Ratio of Aurobindo Pharma Ltd is 24.2 as of 20 May 06:47 AM .a1#The P/E Ratio of Aurobindo Pharma Ltd changed from 19.5 on March 2019 to 15.7 on March 2023 . This represents a CAGR of -4.24% over 5 years. a1#The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1202 as of 18 May 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Aurobindo Pharma Ltd changed from ₹ 46052 crore on March 2019 to ₹ 30351 crore on March 2023 . This represents a CAGR of -8.00% over 5 years. a1#The Revenue of Aurobindo Pharma Ltd changed from ₹ 6276 crore to ₹ 7514 crore over 7 quarters. This represents a CAGR of 10.83% a1#The EBITDA of Aurobindo Pharma Ltd changed from ₹ 973.13 crore to ₹ 1761 crore over 7 quarters. This represents a CAGR of 40.35% a1#The Net Profit of Aurobindo Pharma Ltd changed from ₹ 520.38 crore to ₹ 939.97 crore over 7 quarters. This represents a CAGR of 40.20% a1#The Dividend Payout of Aurobindo Pharma Ltd changed from 9.66 % on March 2019 to 35.71 % on March 2023 . This represents a CAGR of 29.89% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1919.5
Mar '208.5
Mar '219.7
Mar '2214.8
Mar '2315.7

Fundamental Metrics

Market Cap

70,467 Cr

EPS

48.0

P/E Ratio (TTM) *

24.2

P/B Ratio (TTM) *

2.4

Day’s High

1211.65

Day’s Low

1150.25

DTE *

0.2

ROE *

8.2

52 Week High

1211.65

52 Week Low

581.5

ROCE *

10.1

* All values are consolidated

* All values are consolidated

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

PRICE

1202.65

38.80(3.33%)

stock direction

Last updated : 18 May 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value

Market Value

67,972

Asset Value

22,168

2.1 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

2,770 Cr

24.2 X

PE Ratio

Market Cap

₹67971Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

2,770 Cr

24.2 X

PE Ratio

Market Cap

₹67971Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Aurobindo Pharma Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Aurobindo Pharma Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Aurobindo Pharma Ltd's Share Price stands at 1202.65. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-18T00:00:00 is 47.97. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 1202.65/ 47.97= 24.18.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Aurobindo Pharma Ltd's stock is trading at approximately 24.18 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Aurobindo Pharma Ltd’s PE Ratio (BSE: AUROPHARMA)

    The Price-to-Earnings (PE) ratio, used to assess Aurobindo Pharma Ltd's stock (BSE: AUROPHARMA), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1946053
Mar '2024202
Mar '2151653
Mar '2239196
Mar '2330352

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '226277
Sep '225797
Dec '226500
Mar '226608
Jun '236967
Sep '237407
Dec '237514

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '22973
Sep '22847
Dec '221046
Mar '221131
Jun '231195
Sep '231561
Dec '231761

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '22520
Sep '22410
Dec '22491
Mar '22506
Jun '23570
Sep '23752
Dec '23940

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1910
Mar '209
Mar '218
Mar '2236
Mar '2336

* All values are a in %

About Aurobindo Pharma Ltd

About Aurobindo Pharma Ltd

    Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. Glaxo (India), the Indian subsidiary of the UK-based multinational came to an alliance with the company to meet its global bulk drug requirements during the year 1997. During March of the year 2007, the US FDA has granted final approval for the Company's Didanosine Oral Suspension (Pediatric Powder) 10 mg / ml. APL concluded a strategic deal, for acquisition of intellectual property & marketing suthorizations, with TAD Italy, a generic company registered in Italy during March of the year 2008. As a part of this deal, APL also acquired high profile OTC brands - Mapooro and Carmiooro from TAD in same period of the year 2008. On 9 February, 2017, Aurobindo Pharma announced the acquisition of four cell culture derived biosimilar products from TL Biopharmaceutical AG. Mer Medicamentos, Portugal, Generis Phar, Portugal, Pharma APS, Portugal and Generis Mozambique, Portugal. The Board in its meeting held on 16 October 2020 decided to enter into a share purchase agreement to acquire 100% equity share capital of MViyes Pharma Ventures Private Limited. 51% share capital of GLS Pharma Limited was acquired and it became a subsidiary with effect from August 17, 2022.

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma Ltd spurts 3.21%

Aurobindo Pharma Ltd is up for a third straight session in a row. The stock is quoting at ...

Read more

18 May 2024 13:05

News

Aurobindo Pharma to table results

Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 25 May 20...

Read more

17 May 2024 12:42

News

Apitoria Pharma's Unit VII completes USFDA inspection

Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) in...

Read more

10 May 2024 15:03

News

Aurobindo Pharma's Rajasthan-based facility concludes US FDA audit with 7 observations

The inspection was conducted from 25th April 2024 to 3rd May 2024. The inspection closed w...

Read more

04 May 2024 14:38

News

USFDA completes inspection of Eugia Pharma Specialities' Unit II

Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) in...

Read more

03 May 2024 19:20

News

Aurobindo Pharma update on acquisition of balance stake in Purple Bellflower, South Africa

Aurobindo Pharma announced that Aurogen South Africa, South Africa, a wholly owned step-do...

Read more

02 May 2024 14:58

Product Composition by Percentage (Revenue)

FAQs for PE of Aurobindo Pharma Ltd

What is Aurobindo Pharma Ltd current share price?

The current market price of Aurobindo Pharma Ltd as of May 20, 2024 is ₹1202.65.

Is Aurobindo Pharma Ltd a good investment?

As per BlinkX Score Aurobindo Pharma Ltd scores 9 in Revenue, 29 in Profitability. However it's advisable to conduct comprehensive research or seek advice from experts to evaluate whether it aligns with your investment objectives.

What are Aurobindo Pharma Ltd's total net assets?

According to Aurobindo Pharma Ltd's most recent financial filings, the company's net assets total ₹22168.4 Cr.

Is Aurobindo Pharma Ltd making a profit or loss?

Aurobindo Pharma Ltd's net Profit as of May 20, 2024 is close to ₹2,770 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199